Product Information
BANOPHEN 50 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0313 per EA under NDC 00904530760. Its NADAC has been published 665 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904530760
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
11/2/2009
Pharmacological Classes
Price Statistics
The NADAC for BANOPHEN 50 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0313 per EA |
|---|---|
| All-time high | $0.0316 (Jul 15, 2026) |
| All-time low | $0.0176 (May 19, 2021) |
| 52-week high | $0.0316 |
| 52-week low | $0.0219 |
| Median price | $0.0225 |
| Average price | $0.0224 |
| Largest weekly change | +35.2% (Feb 23, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BANOPHEN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 50 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0313 per EA (NDC 00904530760), effective Aug 19, 2026.
How has the price of BANOPHEN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BANOPHEN 50 MG CAPSULE has risen 58.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANOPHEN 50 MG CAPSULE?
Since Nov 28, 2013, the NADAC for BANOPHEN 50 MG CAPSULE has ranged from a low of $0.0176 (May 19, 2021) to a high of $0.0316 (Jul 15, 2026), with a median of $0.0225 per EA.
Are there cheaper alternatives to BANOPHEN 50 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BANOPHEN 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BANOPHEN 50 MG CAPSULE?
BANOPHEN 50 MG CAPSULE (NDC 00904530760) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.